Accountable for 4.4% of global carbon emissions, the pharmaceutical industry is facing mounting pressure to improve its sustainability credentials at every level: from packaging and logistics to the molecular composition of active ingredients and propellants.1
As regulatory and societal expectations increase, manufacturers are uniquely positioned to lead by example.
One of the most impactful strategies they can adopt is a mine-to-market model, which provides end-to-end control of the supply chain.
This enables manufacturers to oversee the entire lifecycle of materials — from raw extraction to final delivery — and gives them the ability to embed sustainability principles at every stage.
In the case of pharmaceutical-grade propellants, for which safety and performance are non-negotiable, this approach has proven to be especially beneficial.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.
